Ni J, Khalid A, Lin YC, Barakat MT, et al. Preclinical safety evaluation of calcineurin inhibitors delivered through an intraductal route to prevent post-ERCP pancreatitis demonstrates endocrine and systemic safety. Pancreatology 2023 Mar 30:S1424-3903(23)00073-X. doi: 10.1016/j.pan.2023.
PMID: 37031049